Simplex Trading’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$556K Sell
8,600
-33,700
-80% -$2.38M ﹤0.01% 3135
2025
Q4
$2.85M Buy
42,300
+16,600
+65% +$1.12M ﹤0.01% 1702
2025
Q3
$1.88M Sell
25,700
-5,300
-17% -$352K ﹤0.01% 2391
2025
Q2
$1.61M Buy
31,000
+8,900
+40% +$506K ﹤0.01% 2300
2025
Q1
$1.41M Sell
22,100
-4,900
-18% -$285K ﹤0.01% 2373
2024
Q4
$1.29M Sell
27,000
-22,500
-45% -$1.15M ﹤0.01% 2602
2024
Q3
$2.83M Buy
49,500
+15,300
+45% +$877K ﹤0.01% 1973
2024
Q2
$1.79M Sell
34,200
-31,100
-48% -$1.36M ﹤0.01% 2311
2024
Q1
$2.66M Buy
65,300
+3,700
+6% +$139K ﹤0.01% 2128
2023
Q4
$2.28M Sell
61,600
-17,000
-22% -$640K ﹤0.01% 2251
2023
Q3
$3M Buy
78,600
+12,500
+19% +$512K ﹤0.01% 1733
2023
Q2
$2.38M Sell
66,100
-22,400
-25% -$764K ﹤0.01% 1830
2023
Q1
$3.38M Buy
88,500
+43,400
+96% +$2.04M ﹤0.01% 1540
2022
Q4
$2.57M Buy
45,100
+32,600
+261% +$1.67M ﹤0.01% 1679
2022
Q3
$494K Buy
12,500
+4,500
+56% +$199K ﹤0.01% 3486
2022
Q2
$352K Buy
8,000
+2,500
+45% +$108K ﹤0.01% 3890
2022
Q1
$219K Sell
5,500
-4,000
-42% -$142K ﹤0.01% 5033
2021
Q4
$381K Sell
9,500
-33,100
-78% -$1.24M ﹤0.01% 4202
2021
Q3
$1.97M Buy
42,600
+100
+0.2% +$4.18K ﹤0.01% 2155
2021
Q2
$1.93M Buy
+42,500
New +$1.88M ﹤0.01% 2210
2021
Q1
Sell
-56
Closed -$239K 9266
2020
Q4
$239K Sell
56
-245
-81% -$8.81K ﹤0.01% 4370
2020
Q3
$791K Sell
301
-913
-75% -$25.4K ﹤0.01% 2497
2020
Q2
$3.25M Buy
1,214
+609
+101% +$13.7K 0.01% 1134
2020
Q1
$1.09M Sell
605
-901
-60% -$17.1K ﹤0.01% 1800
2019
Q4
$2.67M Buy
1,506
+1,146
+318% +$19.8K 0.01% 1244
2019
Q3
$558K Buy
360
+160
+80% +$2.63K ﹤0.01% 2509
2019
Q2
$343K Buy
200
+99
+98% +$1.6K ﹤0.01% 2934
2019
Q1
$162K Sell
101
-26
-20% -$421 ﹤0.01% 3829
2018
Q4
$185K Sell
127
-225
-64% -$3.59K ﹤0.01% 3234
2018
Q3
$639K Buy
352
+296
+529% +$5.18K ﹤0.01% 2369
2018
Q2
$94K Sell
56
-68
-55% -$1.29K ﹤0.01% 4365
2018
Q1
$14K Sell
124
-28
-18% -$542 ﹤0.01% 3693
2017
Q4
$85K Sell
152
-719
-83% -$13.2K ﹤0.01% 1931
2017
Q3
$256K Sell
871
-389
-31% -$5.27K 0.01% 1039
2017
Q2
$99K Buy
1,260
+369
+41% +$4.93K ﹤0.01% 1768
2017
Q1
$77K Sell
891
-796
-47% -$10.1K ﹤0.01% 1975
2016
Q4
$174K Buy
1,687
+701
+71% +$7.68K 0.01% 1144
2016
Q3
$244K Buy
986
+280
+40% +$2.86K 0.02% 896
2016
Q2
$81K Sell
706
-130
-16% -$1.28K 0.01% 1642
2016
Q1
$160K Buy
836
+492
+143% +$4.63K 0.01% 1011
2015
Q4
$106K Buy
344
+243
+241% +$3.87K 0.01% 1300
2015
Q3
$24K Sell
101
-49
-33% -$984 ﹤0.01% 2614
2015
Q2
$87K Buy
150
+29
+24% +$510 0.01% 1298
2015
Q1
$35K Sell
121
-27
-18% -$389 ﹤0.01% 1826
2014
Q4
$7K Buy
+148
New +$1.31K ﹤0.01% 2843

Other funds holding HALO

Simplex Trading's HALO Position: Q3 2025 in Review

Simplex Trading sold out of Halozyme (HALO) in Q3 2025, closing a stake of 1,069 shares — an estimated $71K sold.

Simplex Trading first reported a position in HALO in Q1 2015 and held it in 20 quarters. The position peaked at $870K in Q3 2020. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

  • Simplex Trading reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 1,069 Halozyme shares in Q3 2025, an estimated $71K.
  • Simplex Trading first reported a position in Halozyme in Q1 2015 and held it in 20 quarters.
  • Simplex Trading's Halozyme position peaked at $870K in Q3 2020.
  • 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.